Asthma therapy in the new millennium

Allergology International

Volumn 49, Issue 4, 2000, Pages 231-236

  Holgate, S T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Asthma; Interleukin; T lymphocytes

Indexed keywords

ANTIASTHMATIC AGENT; ANTICYTOKINE AGENT; CELL SURFACE RECEPTOR; CYTOSINE; DNA; DNA VACCINE; EOTAXIN; GAMMA INTERFERON; GUANOSINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MAST CELL INHIBITOR; PEPTIDE; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC DISEASE; ANTIGEN SPECIFICITY; ASTHMA; CELL ACTIVATION; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INFANT NUTRITION; INTERFERON PRODUCTION; LYMPHOCYTE; MAST CELL; MATERNAL NUTRITION; MEDIATOR RELEASE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW;

EID: 0033638802     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1592.2000.00190.x     Document Type: Review

References (32)

1. Reversing the trend: Reducing the prevalence of asthma
2. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent co-stimulatory signals
3. Mechanisms of deficient interferon-γ production in atopic diseases
4. The inverse association between tuberculin response and atopic disorder
5. Role of microbial burden in aetiology of allergy and asthma
6. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae
7. Mycobacterial immunisation in grass pollen immunisation and rhinitis
8. An innate immune defence mechanism based on the recognition of CpG motifs in microbial DNA
9. CpG oligodeoxynucleotides act as adjuvants that switch on T-helper 1 (Th-1) immunity
10. Infection of anti-IgE antibodies will suppress IgE and allergic symptoms
11. Use of an anti-IgE humanised monoclonal antibody in ragweed-induced allergic rhinitis
12. Allergy treatment with a peptide vaccine
13. Assessment of a novel anti-allergy vaccine in subjects with severe food allergy and at risk of anaphylaxis to food
14. Epitope specific antibody response to IgE by mimotope immunisation
15. ITIM-bearing negative coreceptors
16. Tick histamine-binding proteins: Isolation, cloning and three-dimensional structure
17. Airway hyperreactivity and inflammation induced by intratracheal exposure to house dust mite extract in rats
18. 1
19. STAT-6: An intracellular target for the inhibition of allergic diseose
20. Prevention of the development of immediote hypersensitivity and airwoy hyperresponsiveness in vivo with soluble IL-4 receptors
21. Phase I/II study of interleukin-4 receptor (IL-4r) in moderate asthma
22. Requirement for IL-13 independently of IL-4 in experimental asthma
23. Pulmonary expression of interleukin-13 couses inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
24. Design of human interleukin-4 antagonists o inhibiting interleukin-4 dependent and interleukin-13-dependent responses in T cells and B cells with high efficiency
25. An antagonistic IL-4 mutant prevents type I allergy in the mouse: Inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo
26. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation
27. SB 240563, a humanised anti-IL-5 monoclonal antibody: Initial single, dose safety and activity in patents with asthma
28. Chemokines and IL-5: Major ployers of eosinophil recruitment in asthma
29. The importance of CCR-3 demonstroted using an antogonistic monoclonal antibody
30. Immunologic changes associated with allergen immunotherapy
31. Oral gene delivery with chitosan-DNA nanoparticles generate immunological protection in a murine model of peanut ollergy
32. Clinical efficacy of sublingual-swallowed immunotherapy. A double blind placebo-controlled trial of a stondordised five grass pollen extract in rhinitis